Guardian Pharmacy Services Inc

Research Guardian Pharmacy Services Inc (GRDN) on Bullrun: valuation model: 12.2% overvalued, market cap USD 2.56B, P/E 48.4. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerGRDN
• ExchangeNYSE
• CountryUnited States
• SectorHealthcare
• IndustryMedical Care Facilities
• CurrencyUSD
• Valuation signal12.2% overvalued
• Market capUSD 2.56B
• P/E48.4
• Financial periodFY2025
• RevenueUSD 1.45B
• Revenue growth17.9%
• Net incomeUSD 49.22M
• Free cash flowUSD 86.84M
• Gross margin20.2%

Valuation Snapshot

Bullrun's latest valuation model marks Guardian Pharmacy Services Inc as 12.2% overvalued; latest market cap is USD 2.56B; P/E is 48.4.

About Guardian Pharmacy Services Inc

Guardian Pharmacy Services, Inc., a pharmacy service company, provides a suite of technology-enabled services to help residents of long-term health care facilities (LTCFs) in the United States. The company's individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities, behavioral health facilities, and group homes.

Frequently asked questions

Is Guardian Pharmacy Services Inc overvalued or undervalued?

Bullrun's valuation model currently marks Guardian Pharmacy Services Inc as 12.2% overvalued.

What is Guardian Pharmacy Services Inc's market cap?

Guardian Pharmacy Services Inc's market capitalization is USD 2.56B.

What is Guardian Pharmacy Services Inc's P/E ratio?

Guardian Pharmacy Services Inc's price-to-earnings (P/E) ratio is 48.4.

What does Guardian Pharmacy Services Inc do?

Guardian Pharmacy Services, Inc., a pharmacy service company, provides a suite of technology-enabled services to help residents of long-term health care facilities (LTCFs) in the United States.